- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/12 - Antihypertensives
Patent holdings for IPC class A61P 9/12
Total number of patents in this class: 4005
10-year publication summary
|
163
|
134
|
193
|
277
|
260
|
259
|
292
|
297
|
236
|
95
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1848 |
75 |
| Novartis AG | 10975 |
70 |
| Takeda Pharmaceutical Company Limited | 2703 |
57 |
| Actelion Pharmaceuticals Ltd | 536 |
41 |
| Sunshine Lake Pharma Co., Ltd. | 583 |
38 |
| Mitsubishi Tanabe Pharma Corporation | 581 |
36 |
| United Therapeutics Corporation | 305 |
33 |
| Taisho Pharmaceutical Co., Ltd. | 854 |
31 |
| Acceleron Pharma Inc. | 357 |
27 |
| F. Hoffmann-La Roche AG | 7908 |
25 |
| Shionogi & Co., Ltd. | 873 |
25 |
| Dainippon Sumitomo Pharma Co., Ltd. | 200 |
21 |
| Boehringer Ingelheim Vetmedica GmbH | 1264 |
20 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 177 |
20 |
| Nippon Shinyaku Co., Ltd. | 328 |
20 |
| Bayer Pharma AG | 1060 |
19 |
| Regeneron Pharmaceuticals, Inc. | 4201 |
19 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3112 |
19 |
| Janssen Pharmaceutica N.V. | 3437 |
18 |
| Kowa Company, Ltd. | 1196 |
18 |
| Other owners | 3373 |